SeqCure Immunology AB
Developing personalized, non-genetically engineered cell therapy for advanced cancer.
Oversigt
- 1–4
- Medarbejdere
- 1–2.5mio SEK
- Omsætning
- 2016
- Grundlagt
Beskrivelse
SeqCure Immunology is a Stockholm-based biotechnology startup dedicated to advancing cancer immunotherapies. The company is developing SeqCureNEO, a novel, curative, personalized cell therapy designed for treating advanced-stage cancers. This therapy is manufactured using the patient's own isolated...